Aug 19 |
Top US Growth Companies With High Insider Ownership In August 2024
|
Aug 19 |
ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+
|
Aug 8 |
ChromaDex Corporation (CDXC) Q3 2024 Earnings Call Transcript
|
Aug 8 |
ChromaDex Corporation 2024 Q2 - Results - Earnings Call Presentation
|
Aug 7 |
ChromaDex (CDXC) Reports Break-Even Earnings for Q2
|
Aug 7 |
ChromaDex: Q2 Earnings Snapshot
|
Aug 7 |
ChromaDex GAAP EPS of $0.00 beats by $0.01, revenue of $22.7M misses by $0.76M
|
Aug 7 |
ChromaDex Corporation Reports Second Quarter 2024 Financial Results
|
Aug 6 |
ChromaDex Q2 2024 Earnings Preview
|
Aug 5 |
ChromaDex to Present at Canaccord Genuity’s 44th Annual Growth Conference
|